Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen

1 Aug 1996

Abstract excerpt

Resistance to contemporary broad-spectrum beta-lactams, mediated by extended-spectrum beta-lactamase (ESBL) enzymes, is an increasing problem worldwide. The Etest (AB Biodisk, Solna, Sweden) ESBL screen uses stable gradient technology to evaluate the MIC of ceftazidime alone compared with the MIC of ceftazidime with clavulanic acid (2 micrograms/ml) to facilitate the recognition of strains expressing inhibitable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Pharmaceutical and Antibiotic Environmental Impacts

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8818874
DOI: 10.1128/jcm.34.8.1880-1884.1996

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screenPMID 8818874Read ↗

Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.Semantic proximity Read ↗

Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting.Semantic proximity Read ↗

Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests.Semantic proximity Read ↗

Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.Semantic proximity Read ↗

Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coliSemantic proximity Read ↗

Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases.Semantic proximity Read ↗

The cost-effectiveness of ESBL detection: towards molecular detection methods?Semantic proximity Read ↗

Phenotypic detection of beta-lactamase-mediated resistance to oxyimino-cephalosporins in Enterobacteriaceae: evaluation of the Mastascan Elite Expert System.Semantic proximity Read ↗

Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.Semantic proximity Read ↗

Comparison of detection methods for extended-spectrum beta-lactamases in Escherichia coli strains.Semantic proximity Read ↗

Evaluation of a simple phenotypic method for the detection of carbapenemase-producing Enterobacteriaceae.Semantic proximity Read ↗

Acceptable performance of VITEK 2 system to detect extended-spectrum beta-lactamases in clinical isolates of Escherichia coli: a comparative study of phenotypic commercial methods and NCCLS guidelines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.